BATHROOM CITY LIMITED

Financial Health Score: A-

Explanation: Bathroom City Limited is in excellent financial shape, akin to a physically fit individual with a strong immune system. The company boasts robust liquidity, minimal leverage, and a healthy cash position. The slight downgrade from an 'A' grade is due to a recent, albeit deliberate, "surgical procedure"—the write-off of legacy intangible assets—which resulted in a minor dip in retained earnings, and a slight build-up of "cholesterol" in the form of rising stock and debtors that requires monitoring.

Key Vital Signs

1. Pulse & Blood Pressure (Liquidity & Leverage) Current Ratio (2024): 3.91 (Current Assets £2.95M / Current Liabilities £0.75M) Pulse Assessment: The pulse is strong and steady. For every £1 of short-term obligations, the company has £3.91 in short-term assets. This indicates exceptional liquidity and no signs of financial distress. Blood Pressure Assessment: Blood pressure is perfectly low. Total liabilities make up only 25% of total assets, meaning the business is not over-leveraged and is not straining under the weight of debt.

2. Immune System (Cash Reserves) Cash at Bank: £709,718 Assessment: A robust immune system. The cash reserves alone nearly cover all current liabilities, meaning the business can easily fend off unexpected short-term shocks or disruptions without needing external life support (overdrafts or loans).

3. Body Mass (Net Assets) Net Assets (2024): £2,252,665 Assessment: The business carries a solid frame. Net assets have grown significantly over the last five years (up from £1.06M in 2019 to £2.25M in 2024), representing a healthy accumulation of wealth and financial stability.

4. Cholesterol Levels (Debtors & Inventory) Debtors (2024): £1,156,168 (up from £810,398 in 2023) Stocks (2024): £1,086,180 (up from £843,216 in 2023) Assessment: We are seeing a build-up of financial cholesterol. Debtors have increased by 42.6% and stock by 28.8% in a single year. While currently manageable, if these levels continue to harden or block cash flow (bad debts or obsolete stock), they could pose a risk to the company's cardiovascular health.

Diagnosis

The patient is fundamentally robust and in prime condition, but is currently recovering from a deliberate surgical intervention and experiencing some circulatory congestion.

The "Surgical Procedure" (Intangible Asset Write-off) In the 2024 financial year, the company underwent a necessary procedure to remove obsolete technology. The accounts reveal a strategic decision to write off the remaining carrying value of their intangible assets (software/website development costs), resulting in a £315,128 amortisation charge. This caused the P&L reserves to drop slightly (from £2.27M to £2.25M), presenting as a mild financial fever (a reported loss for the year when isolating this write-off). However, much like removing an appendix before it bursts, this was a prudent, proactive measure to cleanse the balance sheet of end-of-life systems ahead of a comprehensive upgrade.

Circulatory Congestion (Working Capital Shifts) While total current assets are healthy, the composition has shifted. Cash dropped from £951k to £709k, while money tied up in debtors and stock surged. This suggests the business is pumping more capital into operational circulation. If debtors are taking longer to pay, or if stock is not moving off the shelves efficiently, the company could experience cramps in its working capital cycle.

Recommendations

1. Cardiovascular Regimen (Manage Debtors & Stock): Put the debtors on a strict collection regimen. The 42% jump in money owed by customers needs to be flushed through the system quickly. Tighten credit control procedures and ensure stock levels are actively turning over, rather than sitting idle in the warehouse.
2. Post-Op Rehabilitation (System Upgrade): The accounts note that the legacy technology write-off is part of a "comprehensive upgrade of our business systems." Ensure this IT rehabilitation is carefully managed to avoid cost overruns, and that the new system delivers the anticipated efficiency gains to justify the investment.
3. Maintain Immune Reserves (Cash Management): While cash is currently strong, the drop from £951k to £709k should be monitored. Aim to convert the newly extended debtor and inventory balances back into cash over the coming year to replenish the immune system to its former strength.